BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang ZZ, Liu YJC, Yin XL, Zhan P, Gu Y, Ni XZ. Loss of BRCA1 expression leads to worse survival in patients with gastric carcinoma. World J Gastroenterol 2013; 19(12): 1968-1974 [PMID: 23569343 DOI: 10.3748/wjg.v19.i12.1968]
URL: https://www.wjgnet.com/1007-9327/full/v19/i12/1968.htm
Number Citing Articles
1
Jun Lu, Mulan Jin, Xiang Zhou, Xin Chen, Yang Shao, Xingran Jiang. Clinicopathological and molecular characteristics of the alpha‐fetoprotein–producing gastric cancer: emphasis on two major subtypesAPMIS 2022; 130(3): 169 doi: 10.1111/apm.13196
2
Cheng Luo, Junxing Chen, Lingwu Chen. Exploration of gene expression profiles and immune microenvironment between high and low tumor mutation burden groups in prostate cancerInternational Immunopharmacology 2020; 86: 106709 doi: 10.1016/j.intimp.2020.106709
3
Elena Maccaroni, Riccardo Giampieri, Edoardo Lenci, Laura Scortichini, Francesca Bianchi, Laura Belvederesi, Cristiana Brugiati, Silvia Pagliaretta, Elisa Ambrosini, Rossana Berardi. BRCA mutations and gastrointestinal cancers: When to expect the unexpected?World Journal of Clinical Oncology 2021; 12(7): 565-580 doi: 10.5306/wjco.v12.i7.565
4
Guangzhong Xu, Kai Li, Nengwei Zhang, Bin Zhu, Guosheng Feng. Screening Driving Transcription Factors in the Processing of Gastric CancerGastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/8431480
5
Joel Del Bel Pádua, Carolline Fontes Alves Mariano, Alexandre Todorovic Fabro, Fermino Sanches Lizarte Neto, Rogério Lenotti Zuliani, Cláudia Tarcila Gomes Sares, José Sebastião dos Santos, Ajith Kumar Sankarankutty, Daniela Pretti da Cunha Tirapelli, Vanessa da Silva Silveira, Greice Andreotti de Molfetta, Wilson Araújo da Silva Júnior, Mariângela Ottoboni Brunaldi. mRNA Expression and Methylation of the RAD51, ATM, ATR, BRCA1, and BRCA2 Genes in Gastric AdenocarcinomaBiomarker Insights 2024; 19 doi: 10.1177/11772719231225206
6
Hee Kim, In Hwang, Hye Min, Yung‑Jue Bang, Woo Kim. Clinical significance of BRCA1 and BRCA2 mRNA and protein expression in patients with sporadic gastric cancerOncology Letters 2019;  doi: 10.3892/ol.2019.10132
7
Geon Kim, Jisu Kim, Su‑Young Han, In Hwang, Hee Kim, Hyeyoung Min. The effects of BRCA1 expression on the chemosensitivity of gastric cancer cells to platinum agentsOncology Letters 2019;  doi: 10.3892/ol.2019.10169
8
Daniel B. Rodrigues, Helena R. Moreira, Mariana Jarnalo, Ricardo Horta, Alexandra P. Marques, Rui L. Reis, Rogério P. Pirraco. Generation of 3D melanoma models using an assembloid-based approachActa Biomaterialia 2024; 178: 93 doi: 10.1016/j.actbio.2024.02.023
9
Ning Zhao, Zicheng Zhang, Qiang Wang, Lin Li, Zichao Wei, Hongyan Chen, Meng Zhou, Zhihua Liu, Jianzhong Su. DNA damage repair profiling of esophageal squamous cell carcinoma uncovers clinically relevant molecular subtypes with distinct prognoses and therapeutic vulnerabilitieseBioMedicine 2023; 96: 104801 doi: 10.1016/j.ebiom.2023.104801
10
Jing Shi, Yi-Ping Qu, Peng Hou. Pathogenetic mechanisms in gastric cancerWorld Journal of Gastroenterology 2014; 20(38): 13804-13819 doi: 10.3748/wjg.v20.i38.13804
11
Elizabeth M Swisher, Kevin K Lin, Amit M Oza, Clare L Scott, Heidi Giordano, James Sun, Gottfried E Konecny, Robert L Coleman, Anna V Tinker, David M O'Malley, Rebecca S Kristeleit, Ling Ma, Katherine M Bell-McGuinn, James D Brenton, Janiel M Cragun, Ana Oaknin, Isabelle Ray-Coquard, Maria I Harrell, Elaina Mann, Scott H Kaufmann, Anne Floquet, Alexandra Leary, Thomas C Harding, Sandra Goble, Lara Maloney, Jeff Isaacson, Andrew R Allen, Lindsey Rolfe, Roman Yelensky, Mitch Raponi, Iain A McNeish. Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trialThe Lancet Oncology 2017; 18(1): 75 doi: 10.1016/S1470-2045(16)30559-9
12
Zhiguo Li, Chen Shao, Yifan Kong, Colin Carlock, Nihal Ahmad, Xiaoqi Liu. DNA Damage Response-Independent Role for MDC1 in Maintaining Genomic StabilityMolecular and Cellular Biology 2017; 37(9) doi: 10.1128/MCB.00595-16
13
Katia De Marco, Paola Sanese, Cristiano Simone, Valentina Grossi. Histone and DNA Methylation as Epigenetic Regulators of DNA Damage Repair in Gastric Cancer and Emerging Therapeutic OpportunitiesCancers 2023; 15(20): 4976 doi: 10.3390/cancers15204976
14
Fernanda S. Manoel-Caetano, Ana Flávia T. Rossi, Gabriela Calvet de Morais, Fábio Eduardo Severino, Ana Elizabete Silva. Upregulation of the APE1 and H2AX genes and miRNAs involved in DNA damage response and repair in gastric cancerGenes & Diseases 2019; 6(2): 176 doi: 10.1016/j.gendis.2019.03.007
15
Yiyin Zhang, Hongyang Wu, Feng Yang, Jie Ning, Min Li, Chenchen Zhao, Shuping Zhong, Kangsheng Gu, Hua Wang. Prognostic Value of the Expression of DNA Repair–Related Biomarkers Mediated by Alcohol in Gastric Cancer PatientsThe American Journal of Pathology 2018; 188(2): 367 doi: 10.1016/j.ajpath.2017.10.010
16
Kole H. Buckley, Blake A. Niccum, Kara N. Maxwell, Bryson W. Katona. Gastric Cancer Risk and Pathogenesis in BRCA1 and BRCA2 CarriersCancers 2022; 14(23): 5953 doi: 10.3390/cancers14235953
17
Bo Wang, Lisha Zhang, Fuman Qiu, Wenxiang Fang, Jieqiong Deng, Yifeng Zhou, Jiachun Lu, Lei Yang, Rui Medeiros. A Newfound Association between MDC1 Functional Polymorphism and Lung Cancer Risk in ChinesePLoS ONE 2014; 9(9): e106794 doi: 10.1371/journal.pone.0106794
18
Yueh-Min Lin, Kun-Tu Yeh, Chung-Min Yeh, Maw-Soan Soon, Li-Sung Hsu. KLF10 Functions as an Independent Prognosis Factor for Gastric CancerMedicina 2022; 58(6): 711 doi: 10.3390/medicina58060711
19
Namrata Setia, Jeffrey W. Clark, Dan G. Duda, Theodore S. Hong, Eunice L. Kwak, John T. Mullen, Gregory Y. Lauwers. Familial Gastric CancersThe Oncologist 2015; 20(12): 1365 doi: 10.1634/theoncologist.2015-0205
20
Katarzyna Starska, Ewa Forma, Maria Nowacka-Zawisza, Iwona Lewy-Trenda, Piotr Ciesielski, Wioletta Pietruszewska, Michał Skóra, Magdalena Bryś. The c.*229C > T gene polymorphism in 3′UTR region of the topoisomerase IIβ binding protein 1 gene and LOH in BRCA1/2 regions and their effect on the risk and progression of human laryngeal carcinomaTumor Biology 2016; 37(4): 4541 doi: 10.1007/s13277-015-4276-3